Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00676871. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant
ClinicalTrials.gov study NCT00833534. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00336206. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00496132. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT02553304. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov study NCT04691765. IPD Sharing: Not stated. Countries: 0. Publications: 0.
S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment
ClinicalTrials.gov study NCT00939328. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab
ClinicalTrials.gov study NCT01131247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00962715. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib.
ClinicalTrials.gov study NCT02611908. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access for Idelalisib in Combination With Rituximab in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02136511. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00076401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997
ClinicalTrials.gov study NCT00899873. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphoc
ClinicalTrials.gov study NCT02556346. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02828774. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
ClinicalTrials.gov study NCT03943342. IPD Sharing: NO. Countries: 0. Publications: 0.
Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02437019. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)
ClinicalTrials.gov study NCT00871546. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00265915. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment
ClinicalTrials.gov study NCT00845104. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.